The company uses AI to give dentists more insight into disease identification and progressionRead more...
Invent Health with Dr. Archana Dubey and Bambi Francisco Roizen; Episode 10
The Invent Health weekly podcast with Dr. Archana Dubey and Bambi Francisco Roizen is the only weekly podcast that breaks down the latest digital health news of the week and what it means for patients, providers and payers (or who's paying). Plus a deep dive on a particular topic to help listeners understand how innovation is changing the healthcare paradigm.
In this episode, the two discuss Stork raising $30 million; Humana buys OneHome and the popularity of the Medicare Advantage vertical, which was also seen in One Medical's acquisition of Iora Health and the recent recovery in Clover Health's stock. OneHome's model is fully-capitated so the two talk about the different value-based models from fully-capitated and bundled and why fully-capitated has limitations but not cutting corners, which some reports criticize fully-capitated models to potentially do.
Also in the news this past week, Brightline raising $72 million to expand its behavioral care services to kids; Google is reportedly downsizing its healthcare unit as it moves 130 of its 700 staffers in its healthcare division to Fitbit. The report says that Google Health lead David Feinberg said Google's consumer healthcare innovations will move faster with this shift. Plus 23andMe goes public via a SPAC as it merged with Richard Branson's VG Acquisition Corp. The company, a pioneer in at-home genetic testing, trades under the ticker symbol "ME" and is now valued at $1.5 billion. And the deep dive this week was in "Primary Care" and the challenges of driving more consumers to use primary care to avoid costly secondary care. The problem as Archana explains, as she is a primary care physician, is that PCPs don't have time so they do prescribe a lot of medications, from cholesterol-reducing medications, to antibiotics to antidepressants. If society wants PCPs to stop prescribing medications, they need to give them more time with patients and stop with the assembly-line model. Indeed, as Bambi notes, 79% of psychotropics are prescribed by PCPs.
Editor's note: On July 14, we'll continue our Future of Mental and Behavioral Health 2021 virtual series. Use "inventhealth" for a complimentary ticket! This year's event hosted top-level VCs and C-level executives from the leading mental and behavioral companies, such as Teladoc's BetterHelp, K Health, BetterUp, Ginger, Amwell, Doctor on Demand, Kaiser Permanente, Bessemer Ventures and more.
Support VatorNews by Donating
Read more from our "Podcast" series
Clipboard Health is a healthcare staffing marketplace that was recently valued at $1.3 billionRead more...
NovaSignal uses AI and robotics to identify blood clots and other neurological abnormalitiesRead more...
Related Companies, Investors, and Entrepreneurs
Joined Vator onFounder and CEO of Vator, a media and research firm for entrepreneurs and investors; Managing Director of Vator Health Fund; Co-Founder of Invent Health; Author and award-winning journalist.